Holoclara
6 known investors
Holoclara develops therapeutics derived from symbiotic intestinal organisms (helminths) that modulate inflammation, metabolism, and tissue regeneration to address chronic disease, immune-related conditions, and aging. The company aims to reintroduce beneficial worm-derived components without live worms.
BiotechHealthtechLongevity
Founders & leadership
AC
Andrea ChoeCEO / Co-Founder
PW
Paul W. SternbergCo-Founder
FC
Frank C. SchroederCo-Founder
Investors · 6
In the news
Frequently asked questions
- What does Holoclara do?
- Holoclara develops therapeutics derived from symbiotic intestinal organisms (helminths) that modulate inflammation, metabolism, and tissue regeneration to address chronic disease, immune-related conditions, and aging. The company aims to reintroduce beneficial worm-derived components without live worms.
- Who founded Holoclara?
- Holoclara was founded by Andrea Choe, Paul W. Sternberg, Frank C. Schroeder.
- Who are Holoclara's investors?
- Holoclara's investors include Horizons Ventures, BOLD Capital, Bold Capital Partners, FREEFLOW, Kairos Venture Investments, Llc, Endurance28.